@inproceedings{volosincu-etal-2023-fii,
title = "{FII} {SMART} at {S}em{E}val 2023 Task7: Multi-evidence Natural Language Inference for Clinical Trial Data",
author = "Volosincu, Mihai and
Lupu, Cosmin and
Trandabat, Diana and
Gifu, Daniela",
editor = {Ojha, Atul Kr. and
Do{\u{g}}ru{\"o}z, A. Seza and
Da San Martino, Giovanni and
Tayyar Madabushi, Harish and
Kumar, Ritesh and
Sartori, Elisa},
booktitle = "Proceedings of the 17th International Workshop on Semantic Evaluation (SemEval-2023)",
month = jul,
year = "2023",
address = "Toronto, Canada",
publisher = "Association for Computational Linguistics",
url = "https://preview.aclanthology.org/jlcl-multiple-ingestion/2023.semeval-1.30/",
doi = "10.18653/v1/2023.semeval-1.30",
pages = "212--220",
abstract = "The {\textquotedblleft}Multi-evidence Natural Language Inference forClinical Trial Data{\textquotedblright} task at SemEval 2023competition focuses on extracting essentialinformation on clinical trial data, by posing twosubtasks on textual entailment and evidence retrieval. In the context of SemEval, we present a comparisonbetween a method based on the BioBERT model anda CNN model. The task is based on a collection ofbreast cancer Clinical Trial Reports (CTRs),statements, explanations, and labels annotated bydomain expert annotators. We achieved F1 scores of0.69 for determining the inference relation(entailment vs contradiction) between CTR -statement pairs. The implementation of our system ismade available via Github - \url{https://github.com/volosincu/FII_Smart__Semeval2023}."
}
Markdown (Informal)
[FII SMART at SemEval 2023 Task7: Multi-evidence Natural Language Inference for Clinical Trial Data](https://preview.aclanthology.org/jlcl-multiple-ingestion/2023.semeval-1.30/) (Volosincu et al., SemEval 2023)
ACL